Résumé
L’obésité est maintenant clairement associée au développement et à la majoration du risque de maladie rénale chronique (MRC). La question de savoir quels sont les outils les plus performants pour préciser ce risque se pose chez le sujet obèse. La MRC est définie par deux paramètres: le débit de filtration glomérulaire (DFG) et la protéinurie (albuminurie). Les différents moyens d’estimer le DFG seront discutés. En raison d’une perte de proportionnalité entre le gain de masse maigre et celui de masse grasse, la simple concentration plasmatique de créatinine ainsi que la formule de Cochroft ne sont plus recommandées pour estimer le DFG. Actuellement, en l’absence de formule spécifiquement élaborée et validée au cours de l’obésité, la formule du modification of diet in renal disease (MDRD) représente la méthode de choix, conformément aux recommandations K/DIGO 2010 (Kidney Disease Outcome Quality Initiative) élaborées pour le sujet de corpulence normale. Concernant la protéinurie, le recueil urinaire des 24 heures doit être abandonné en première intention au profit du calcul du ratio protéinurie/créatinurie sur un échantillon d’urine. Ce ratio s’exprime en milligramme par gramme, et sa classification en trois stades fait partie intégrante de l’évaluation de la MRC du sujet obèse.
Abstract
Obesity is clearly associated with the development and increased risk of chronic kidney disease (CKD). The question of which tools are better for clarifying this risk arises in obese patients. CKD is defined by two parameters: glomerular filtration rate (GFR) and proteinuria (albuminuria). The different ways of estimating GFR will be discussed. Due to a lack of proportionality between lean mass and fat mass gains, plasma creatinine and Cochcroft formula are no longer recommended for estimating GFR. There is no formula specifically developed and validated for obesity. Currently, the formula of Modification of Diet in Renal Disease (MDRD) is the preferred method, as recommended by K/DIGO 2010 (Kidney Disease Outcome Quality Initiative) for a human with normal weight. As far as proteinuria, is concerned 24 hours urine collection must be abandoned in favour of proteinuria/creatinuria ratio form a urine sample. This ratio is expressed in mg/g and this classification into three grades is part of the evaluation of CKD in obese patients.
Références
Go AS, Chertow GM, Fan D, et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305
Levey AS, de Jong PE, Coresh J, et al (2010) The definition, classification and prognosis of chronic kidney disease: a K/DIGO Controversies Conference report. Kidney Int [Epub ahead of print]
Praga M (2002) Obesity: a neglected culprit in renal disease. Nephrol Dial Transplant 17:1157–1159
Iseki K, Ikemiya Y, Kinjo K, et al (2004) Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65:1870–1876
Hsu CY, McCulloch CE, Iribarren C, et al (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28
Prigent A (2008) Monitoring renal function and limitations of renal function tests. Semin Nucl Med 38:32–46
Levey AS, Coresh J, Balk E, et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147
Delanaye P, Mariat C, Cavalier E, Krzesinski JM (2009) Indexing glomerular filtration rate for body surface area: myth and reality. Nephrol Ther 5:614–622
Michels WM, Grootendorst DC, Verduijn M, et al (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5:1003–1009
Levey AS, Stevens LA, Schmid CH, et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Demirovic JA, Pai AB, Pai MP (2009) Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm 66:642–648
Stevens LA, Coresh J, Schmid CH, et al (2008) Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51:395–406
Vupputuri S, Fox CS, Coresh J, et al (2009) Differential estimation of CKD using creatinine versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 53:993–1001
Friedman AN, Strother M, Quinney SK, et al (2010) Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron Clin Pract 116:c224–c234
Taleb S, Cancello R, Clement K, Lacasa D (2006) Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 147:4950–4959
Kratchmarova I, Kalume DE, Blagoev B, et al (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 1:213–222
Knight EL, Verhave JC, Spiegelman D, et al (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416–1421
Elsayed EF, Sarnak MJ, Tighiouart H, et al (2008) Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52:29–38
Kim SR, Yoo JH, Song HC, et al (2010) Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant [Epub ahead of print]
Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379–384
Lastra G, Manrique C, Sowers JR (2006) Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 13:365–373
Foster MC, Hwang SJ, Larson MG, et al (2008) Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52:39–48
Cirillo M (2010) Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol 23:125–132
Foster MC, Hwang SJ, Massaro JM, et al (2010) Association of subcutaneous and visceral adiposity with albuminuria: The Framingham Heart Study. Obesity (Silver Spring) [Epub ahead of print]
Bello AK, de Zeeuw D, El Nahas M, et al (2007) Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 22:1619–1627
Hofso D, Nordstrand N, Johnson LK, et al (2010) Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 163:735–745
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allard, J. Évaluation de la fonction rénale du sujet obèse. Obes 6, 7–10 (2011). https://doi.org/10.1007/s11690-011-0252-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-011-0252-2